For diagnostics laboratories
You bill high volumes of low-dollar claims against orders written by people who do not work for you. That single structural fact drives most of what goes wrong downstream, and it is why headcount scales with volume unless something changes upstream.
The structural difference
A physician practice registers its own patients. A laboratory receives a specimen and a requisition from an ordering practice that has no billing stake in whether the demographics are complete, the diagnosis code supports the test, or the insurance on file is current.
Everything downstream inherits that. The claim is already compromised before your billing team sees it, and the fix requires calling someone else’s office. That is the loop worth automating, not the claim submission, which is usually already clean by the time it goes out.
Volume without dollar cushion
A hospital can afford twenty minutes of staff time chasing a claim worth four thousand dollars. On a routine panel, the cost of the chase can exceed the reimbursement. Manual follow-up is not just slow here. On a large share of your book it is economically irrational, which is why so much gets written off silently.
Medical necessity lives in someone else’s note
Coverage determinations turn on documentation you do not hold. When a payer wants the record supporting the test, retrieving it means a request to the ordering practice, then waiting. Molecular and genetic testing makes this worse, because the coverage policies are long, specific, and revised often.
Payer mix churns constantly
You are not managing a stable panel of contracts for a known patient population. New ordering clients bring new plans, and out-of-network volume arrives unannounced. Rules built for last quarter’s mix quietly stop matching this quarter’s.
Turnaround pressure is clinical, not financial
The specimen has to be resulted whether or not the billing information is complete. So the test gets run, the result goes out, and the billing problem is discovered afterwards, with the leverage gone and the clock already running.
Scope
Almost always at intake rather than at the claim. Fixing a requisition before the test is resulted is worth more than working the denial three weeks later, and it costs less.
Proof
Our deepest engagement is a national cancer diagnostics laboratory, running continuously since 2018 and still expanding. Prior authorization came first; intake, appeals and case assignment followed.
The reason it is worth citing is not the launch numbers. It is the eighth year. Most lab automation programs decay when payer portals change and nobody owns maintenance. Longevity is the harder claim, and it is the one we would want you to check.
Questions labs ask
Do you work with our LIS and billing system?
Yes, and we do not replace either. We work against whatever interface your systems expose: a standard transaction, an extract, a service account, or screen-level automation where nothing else is available. Being tool-agnostic is the point.
We are a small lab. Is this worth it?
The economics work when one workflow consumes more than roughly one full-time equivalent per week. Below that we will tell you not to. Run the numbers yourself before you talk to us.
Most of our requisitions still arrive by fax. Does that break this?
No. It is the normal case and one of the places a model genuinely earns its place, because reading varied documents is exactly what rules are bad at. Extraction gets reviewed before it drives anything downstream.
Will this touch patient data?
Yes, by definition. We operate under a BAA, work inside your environment, and de-identify clinical text before any model sees it. Our security positions.
Next step
Thirty minutes on your requisition flow, your payer mix and your top denial reasons. You leave with a one-page map of what is automatable, ranked by hours recovered per week, yours either way.
Book a teardown